Expression and relative abundance of the 35–kDa cyclin D1 in AML 12 mouse hepatocytes exposed to PCP and NRG1-β + PCP treatments for 48 h are shown in Figure 7. The gene discussed is CCND1; the disease is pneumocystosis.